wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38012528-81BA400B-E452-43D7-A2B8-7012E679208C
Q38012528-81BA400B-E452-43D7-A2B8-7012E679208C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38012528-81BA400B-E452-43D7-A2B8-7012E679208C
Management of metastatic castration-resistant prostate cancer: recent advances.
P2860
Q38012528-81BA400B-E452-43D7-A2B8-7012E679208C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38012528-81BA400B-E452-43D7-A2B8-7012E679208C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bf854c71c85d4f3b271dd77632f4fa8edeb96ccd
P2860
Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.